Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Deadline Approaching: Apply for the Fierce AI Innovation Awards
Belgium
Manufacturing
Ardena reaps rewards from CDMO specialization plays, US plant buy
Ardena is benefitting from a well-timed U.S. expansion move and continued interest in its specialized nanomedicine focus, the CDMO's CEO told Fierce.
Fraiser Kansteiner
Apr 7, 2026 8:24am
Nanologica acquires Ardena's Syntagon API facility in stock deal
Feb 4, 2026 8:45am
Catalent moves to wind down operations at EU cell therapy hub
Jan 26, 2026 3:16pm
J&J, Legend to invest $150M in Belgium cell therapy facility
Mar 12, 2025 2:15pm
SpectronRx nears completion of Belgian radiopharmaceutical plant
Oct 17, 2024 6:00am
Catalent sells NJ production plant, HQ to Belgium's Ardena
Oct 14, 2024 9:53am